Vindhya International Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Vindhya International Pharmaceutical Export Portfolio Dataset — 2 Products, $153.6K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Vindhya International — Pharmaceutical Exporter Profile (2026) | 2 Products, $153.6K Trade | TransData Nexus

Vindhya International

Indian Pharmaceutical Exporter · Nutritional Supplements Specialist · $153.6K Total Trade · DGFT Verified

Vindhya International is an Indian pharmaceutical exporter with a total trade value of $153.6K across 2 products in 2 therapeutic categories. Based on 20 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Protein ($131.8K), Vinblastine ($21.8K), .

Vindhya International — Export Portfolio & Destination Treemap

Vindhya International pharmaceutical export portfolio — 2 products across 2 therapeutic categories. Source: Indian Customs (DGFT).

Who is Vindhya International? — Company Overview & Market Position

Vindhya International is an Indian pharmaceutical exporter specializing in finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Established in 2015, the company is headquartered in Chhatral, Gandhinagar, Gujarat, a region renowned as a manufacturing hub for pharmaceutical formulations in India. The company operates as a partnership firm, with a dedicated team committed to delivering quality products globally.

Vindhya International's product portfolio encompasses a diverse range of therapeutic categories, including oncology, anti-depressants, anti-anxiety, anti-migraine, anti-psychotics, anti-ADHD, anti-smoking, anti-viral, erectile dysfunction, hepatitis C, hair loss, hormone products, mood stabilizers, anticonvulsants, sedative hypnotics, vaccines, and eye and ear drops. This extensive range underscores the company's commitment to addressing various health concerns through its pharmaceutical offerings.

What Does Vindhya International Export? — Product Portfolio Analysis

Top Products by Export Value

1Protein$131.8K 2

Product Portfolio — Top 2 by Export Value

Vindhya International exports 2 pharmaceutical products across 2 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Protein	Nutritional Supplements	$131.8K	7	0.9%	10
2	Vinblastine	Oncology	$21.8K	13	2.9%	9

Vindhya International exports 2 pharmaceutical products across 2 therapeutic categories with a total export value of $153.6K. The top category is Nutritional Supplements (85.8% of portfolio), followed by Oncology (14.2%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Vindhya International — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Vindhya International operates manufacturing facilities in Gujarat, India, a region recognized for its robust pharmaceutical manufacturing infrastructure. The company specializes in producing a wide array of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. These facilities are equipped to handle the production of both generic and branded medicines, catering to diverse therapeutic areas such as oncology, anti-depressants, anti-anxiety, anti-migraine, anti-psychotics, anti-ADHD, anti-smoking, anti-viral, erectile dysfunction, hepatitis C, hair loss, hormone products, mood stabilizers, anticonvulsants, sedative hypnotics, vaccines, and eye and ear drops.

3Key Leadership

Specific details regarding the key leadership of Vindhya International are not publicly disclosed. The company's official website and available public records do not provide information about the CEO, CFO, or other key executives. This lack of publicly available information may be due to the company's private ownership structure and limited public disclosures.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Vindhya International Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Vindhya International's export activities are primarily focused on finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. The company's total export value is $154,000 USD, with 20 shipments across two therapeutic categories: Nutritional Supplements (85.8%) and Oncology (14.2%). The top five products exported are Protein ($132,000, Rank #10, 0.9% market share) and Vinblastine ($22,000, Rank #9, 2.9% market share). The company's portfolio concentration is high, with the top five products accounting for 100% of the export value.

While Vindhya International's export data indicates a presence in regulated markets, specific details regarding regulatory filings, approvals, and market access status in the US, EU, UK, Australia, and Japan are not publicly available. This lack of information may be due to the company's private ownership structure and limited public disclosures.

2Emerging Markets

Vindhya International's export data indicates a focus on finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. The company's total export value is $154,000 USD, with 20 shipments across two therapeutic categories: Nutritional Supplements (85.8%) and Oncology (14.2%). The top five products exported are Protein ($132,000, Rank #10, 0.9% market share) and Vinblastine ($22,000, Rank #9, 2.9% market share). The company's portfolio concentration is high, with the top five products accounting for 100% of the export value.

Vindhya International — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific details regarding Vindhya International's FDA facility registrations, approved ANDAs, DMF filings, and inspection history are not publicly available. This lack of information may be due to the company's private ownership structure and limited public disclosures.

2WHO & EU GMP

Specific details regarding Vindhya International's WHO prequalification, EU GMP certificates, and EDQM status are not publicly available. This lack of information may be due to the company's private ownership structure and limited public disclosures.

3CDSCO & Indian Regulatory

Specific details regarding Vindhya International's CDSCO manufacturing licenses, state drug controller approvals, and export NOCs are not publicly available. This lack of information may be due to the company's private ownership structure and limited public disclosures.

Recent Regulatory Actions

Vindhya International — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Specific details regarding Vindhya International's top competitors in overlapping categories, market share comparison, and head-to-head analysis are not publicly available. This lack of information may be due to the company's private ownership structure and limited public disclosures.

2Key Differentiators

Specific details regarding Vindhya International's unique strengths, competitive advantages, and product portfolio distinctions are not publicly available. This lack of information may be due to the company's private ownership structure and limited public disclosures.

3Strategic Position

Specific details regarding Vindhya International's current strategic direction—whether in generics, specialty, biosimilars, or CDMO—and future outlook are not publicly available. This lack of information may be due to the company's private ownership structure and limited public disclosures.

TransData Nexus Research · DGFT export records, industry analysis

Buyer Due Diligence Brief — Evaluating Vindhya International as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Specific details regarding Vindhya International's overall track record, export volume and consistency, and reliability indicators are not publicly available. This lack of information may be due to the company's private ownership structure and limited public disclosures.

2Certifications to Verify

Specific certifications that importers should verify for Vindhya International—such as FDA, WHO-GMP, EU GMP, ISO—and how to verify each are not publicly available. This lack of information may be due to the company's private ownership structure and limited public disclosures.

3Due Diligence Checklist

Given the limited publicly available information on Vindhya International, importers are advised to undertake comprehensive due diligence, including:

Directly contacting the company to request detailed information on certifications, regulatory approvals, and quality assurance processes.

Frequently Asked Questions — Vindhya International

How many pharmaceutical products does Vindhya International export from India?

Vindhya International exports 2 pharmaceutical products across 2 therapeutic categories. The top exports are Protein ($131.8K), Vinblastine ($21.8K). Total export value is $153.6K.

What is Vindhya International's total pharmaceutical export value?

Vindhya International's total pharmaceutical export value is $153.6K, based on 20 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Vindhya International cover?

Vindhya International exports across 2 therapeutic categories. The largest are Nutritional Supplements (85.8%, 1 products), Oncology (14.2%, 1 products).

Get Full Vindhya International Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.